Novanta just made a $1.2bn surgical consumables bet. Can Riverpoint justify the price?
Novanta completes Riverpoint Medical acquisition, expanding surgical consumables and recurring revenue. See what integration and returns must deliver.
Medical Devices & Diagnostics